PLBY PLBY Group Inc

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

PLBY Group, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)

72814P109

(CUSIP Number)

Raffaele Zucca Alessandrelli

Docler Holding S.à r.l.

44 avenue John F. Kennedy

L-1855 Luxembourg

Grand Duchy of Luxembourg

+352 261 11 81

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

November 5, 2024

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because § 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g) check the following box ☐.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the

purpose of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section of the Exchange Act but shall be subject to all other provisions of the Exchange Act (however, see the Notes).

CUSIP No. 72814P109

CUSIP No. 72814P109

CUSIP No. 72814P109

This Schedule 13D relates to the common stock, par value $0.0001 per share (“Common Stock”), of PLBY Group, Inc., a Delaware corporation (the “Issuer”). The address of the principal executive office of the Issuer is 10960 Wilshire Blvd., Suite 2200, Los Angeles, California 90024.

Byborg is a subsidiary of Docler. The Million is a wholly owned subsidiary of Byborg.

Information regarding the executive officers, directors or other control persons of the Reporting Persons is set forth on Schedule I attached hereto, which Schedule is hereby incorporated by reference.

The Reporting Persons acquired 14,900,000 shares of Common Stock at a price of $1.50 per share, for an aggregate purchase price of $22.35 million. The source of funds was the working capital of Byborg and some of its subsidiaries. Item 6 of this Schedule 13D is hereby incorporated by reference into this Item 3.

The Reporting Persons acquired the shares of Common Stock set forth in Item 5 and hold their shares of Common Stock for investment purposes.

Item 6 of this Schedule 13D is hereby incorporated by reference into this Item 4.

See the information under the caption “Standstill Agreement” in Item 6 of this Schedule 13D. Each Reporting Person expects to continuously review such person’s investment in the Issuer and, depending on various factors including but not limited to, the price of the shares of Common Stock, the terms and conditions of the transaction, prevailing market conditions and such other considerations as such Reporting Person deems relevant, may at any time or from time to time, and subject to any required regulatory approvals and the terms of the Standstill Agreement (as defined in Item 6 below), acquire additional shares of Common Stock, preferred stock or other securities convertible into or exercisable or exchangeable for Common Stock from time to time on the open market, in privately- negotiated transactions, directly from the Issuer, or upon the exercise or conversion of securities convertible into or exercisable or exchangeable for Common Stock. See the information under the caption “Potential License Agreement” in Item 6 of this Schedule 13D.

See the information under the caption “Potential License Agreement” in Item 6 of this Schedule 13D. Consistent with their investment intent, each Reporting Person may from time to time discuss with the Issuer’s management, directors, other shareholders and others, the Issuer’s performance, business, strategic direction, capital structure, product development program, prospects and management, as well as various ways of maximizing stockholder value, which may or may not include extraordinary transactions. There is no assurance that any such transaction will develop or materialize, or if it does, as to its timing or whether the Reporting Persons will participate.

Except as indicated herein, no Reporting Person, as a stockholder of the Issuer, has any plans or proposals that relates or would result in any of the transactions or other matters specified in clauses (a) though (j) of Item 4 of Schedule 13D. Each Reporting Person may, at any time and from time to time, review or reconsider its or his position and/or change its or his purpose and/or formulate plans or proposals with respect thereto.

(a) and (b)

The information set forth in rows 11 and 13 of the cover pages to this Schedule 13D is incorporated by reference. The percentage set forth in row 13 was calculated based on approximately 89.5 million shares of Common Stock issued and outstanding as of November 5, 2024, as reported by the Issuer in its press release dated November 5, 2024, and attached as Exhibit 99.1 to its Current Report on Form 8-K filed with the SEC on November 5, 2024.

The Million directly holds 14,900,000 shares of Common Stock of the Issuer. Byborg is a subsidiary of Docler. Million is a wholly owned subsidiary of Byborg.

(c) Except as disclosed in this Schedule 13D, the Reporting Persons have not effected any transaction in the shares of Common Stock of the Issuer during the past 60 days.

(d) No person other than the persons listed is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any securities owned by any member of the group.

(e) Not applicable.

Purchase Agreement

On October 30, 2024, Byborg entered into a Securities Purchase Agreement (the “Purchase Agreement”) with the Issuer pursuant to which Byborg agreed to purchase (either itself or through an affiliate) 14,900,000 newly issued shares of Common Stock of the Issuer for a price of $1.50 per share, for a total purchase price of $22.35 million (the “Private Placement”). Subject to certain exceptions set forth in the Purchase Agreement, neither Byborg nor any of its affiliates may transfer any of the shares of Common Stock purchased in the Private Placement to any unaffiliated person until the one-year anniversary of the closing of the Private Placement. The Issuer also granted certain limited registration rights to Byborg and its affiliates for registration of the resale of the shares of Common Stock purchased in the Private Placement after the one-year anniversary of the closing.

In addition, pursuant to the Purchase Agreement, the Issuer has agreed to increase the size of its Board of Directors (the “Board”) from five to seven directors as of January 1, 2025. As of that date, the Board will add a new independent director mutually agreed by the Issuer and Byborg, and Byborg will have the right to nominate one individual to serve on the Board. Byborg will retain such right until such time as it beneficially owns less than 7,450,000 shares of Common Stock. Prior to the closing of the Private Placement, Byborg assigned its rights under the Purchase Agreement to The Million, and Issuer delivered the shares of Common Stock to The Million at the closing of the transaction contemplated by the Purchase Agreement on November 5, 2024.

The foregoing description of the Purchase Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Purchase Agreement, which is filed as Exhibit 2 hereto and is incorporated herein by reference.

Standstill Agreement

On October 30, 2024, Byborg entered into a standstill agreement (the “Standstill Agreement”) with the Issuer. Pursuant to the Standstill Agreement, among other limitations, Byborg and its affiliates agreed not to (i) join or participate in a “group” (as defined in Sections 13(d)(3) and 13(g)(3) of the Securities Exchange Act of 1934, as amended) with any third party, or (ii) purchase shares of Common Stock that would result in Byborg and its affiliates owning in excess of 29.99% of the Issuer’s outstanding Common Stock in the aggregate following any acquisition of Common Stock, in each case, during the standstill period. The standstill period means any time from and after October 30, 2024 in which Byborg and its affiliates collectively own, beneficially or of record, more than 14.9% of the total outstanding shares of Common Stock.

The foregoing description of the Standstill Agreement does not purport to be complete and is qualified in its entirety by reference to the full text of the Standstill Agreement, which is filed as Exhibit 4 hereto and is incorporated herein by reference.

Planned Licensing Agreement

Byborg and the Issuer have also signed a non-binding letter of intent (“LOI”) providing that the parties will work together on an exclusive basis to negotiate and execute a definitive agreement pursuant to which Byborg would license certain of the Issuer’s digital intellectual property and operate certain digital businesses. The Issuer and Byborg expect to enter into definitive agreements prior to year-end. In addition, pursuant to the non-binding LOI, the Reporting Persons may acquire additional equity of the Issuer pursuant to a subsequent purchase agreement with the Issuer or otherwise, subject to the terms of the Standstill Agreement, upon such terms as to be negotiated with the Issuer in connection with the negotiation of the licensing agreement.

Item 7. Material to Be Filed as Exhibits

SIGNATURES

After reasonable inquiry and to the best of my knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct.

Dated: November 13, 2024

Schedule I

CONTROL PERSONS AND EXECUTIVE OFFICERS OF REPORTING PERSONS

The name, business address, country of citizenship, present principal occupation or employment and the name, principal business and address of any corporation or other organization in which such employment is conducted, of each of the executive officers and other control persons of the Reporting Persons are set forth below:

Docler Holding S.à r.l.

Byborg Enterprises S.A.

The Million S.à r.l.

Exhibit 1

Joint Filing Agreement

This will confirm the agreement by and among all the undersigned that the Schedule 13D filed on or about this date and any amendments thereto with respect to the beneficial ownership by the undersigned of shares of common stock, par value $0.0001 per share, of PLBY Group, Inc. is being filed on behalf of each of the undersigned in accordance with Rule 13d-1(k)(1). This agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

Dated: November 13, 2024